Biblio Discovery — Demo Discovery Service

15 results for "Yuwan Lin"

Showing 1–15 · 6.07 seconds · RSS

  1. Journal Article

    Transaldolase 1 impacts Parkinson’s disease pathogenesis via metabolic reprogramming and autophagy-lysosomal pathway

    Zixin Tan; Huimin Hu; Hao Chen et al.

    Acta Neuropathologica Communications, Vol. 13 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Parkinson’s disease (PD) progression involves dopaminergic neurodegeneration and pathological α-synuclein aggregation, processes linked to metabolic dysregulation and autophagy-lysosomal pathway (ALP) impairment. Transaldolase1 (TAL1) is a key enzyme of the pentose phosphate pathway. While…

  2. Journal Article

    Integrated analysis of copy number variation-associated lncRNAs identifies candidates contributing to the etiologies of congenital kidney anomalies

    Yibo Lu; Yiyang Zhou; Jing Guo et al.

    Communications Biology, Vol. 6 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Congenital anomalies of the kidney and urinary tract (CAKUT) are disorders resulting from defects in the development of the kidneys and their outflow tract. Copy number variations (CNVs) have been identified as important genetic variations leading to CAKUT, whereas most CAKUT-associated…

  3. Journal Article

    Copy number variation-associated lncRNAs may contribute to the etiologies of congenital heart disease

    Yibo Lu; Qing Fang; Ming Qi et al.

    Communications Biology, Vol. 6 No. 1 · 2023 · English · DOAJ Scopus

    A transcriptomic analysis of lncRNAs within copy-number variations identifies HSALNG0104472 as a potential lncRNA effector of cardiac defects in non-syndromic congenital heart disease.

  4. Journal Article

    Association of LAG3 genetic variation with an increased risk of PD in Chinese female population

    Wenyuan Guo; Miaomiao Zhou; Jiewen Qiu et al.

    Journal of Neuroinflammation, Vol. 16 No. 1 · 2019 · English · DOAJ Scopus

    Abstract Background Emerging evidence suggests that α-synuclein (α-syn) aggregation and intercellular transmission contributes to pathogenesis of Parkinson’s disease (PD) and the toxic fibrillary α-syn binds lymphocyte-activation gene 3 (LAG3) receptor that mediates α-syn transmission. The deletion…

  5. Journal Article

    Cellular and synaptic mechanisms for Parkinson’s disease-related chronic pain

    Jing-Shan Lu; Qi-Yu Chen; Xiang Chen et al.

    Molecular Pain, Vol. 17 · 2021 · English · DOAJ Scopus

    Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. Chronic pain is experienced by the vast majority of patients living with Parkinson’s disease. The degeneration of dopaminergic neuron acts as the essential mechanism of Parkinson’s disease in the…

  6. Journal Article

    Bone-Derived Factors as Potential Biomarkers for Parkinson’s Disease

    Yuwan Lin; Miaomiao Zhou; Wei Dai et al.

    Frontiers in Aging Neuroscience, Vol. 13 · 2021 · English · DOAJ Scopus

    Background: Parkinson’s disease (PD) and osteoporosis are both common aging diseases. It is reported that PD has a close relationship with osteoporosis and bone secretory proteins may be involved in disease progression.Objectives: To detect the bone-derived factors in plasma and cerebrospinal fluid…

  7. Journal Article

    CHCHD2 maintains mitochondrial contact site and cristae organizing system stability and protects against mitochondrial dysfunction in an experimental model of Parkinson's disease

    Lin Lu; Hengxu Mao; Miaomiao Zhou et al.

    Chinese Medical Journal, Vol. 135 No. 13 · 2022 · English · DOAJ Scopus

    Background:. Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's dementia. Mitochondrial dysfunction is involved in the pathology of PD. Coiled-coil-helix-coiled-coil-helix domain-containing 2 (CHCHD2) was identified as associated with autosomal dominant…

  8. Journal Article

    Reduced regional activity and functional connectivity within sensorimotor network in Parkinson’s patients with restless legs syndrome

    Zhe Li; Jun Chen; Yuwan Lin et al.

    Molecular Pain, Vol. 15 · 2019 · English · DOAJ Scopus

    Background Restless legs syndrome is an important sleep disturbance in Parkinson’s disease. Restless legs syndrome causes an urge to move the legs accompanying sensations which can be difficult to describe but include aching, burning, tingling, or crawling. However, the underlying pathophysiology…

  9. Journal Article

    Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson’s Disease

    Mingshu Mo; Yuting Tang; Lijian Wei et al.

    Frontiers in Aging Neuroscience, Vol. 13 · 2021 · English · DOAJ Scopus

    Background: Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial receptor exclusively expressed in the central nervous system (CNS). It contributes to abnormal protein aggregation in neurodegenerative disorders, but its role in Parkinson’s disease (PD) is still unclear.Methods…

  10. Journal Article

    Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson’s Disease Model

    Shuxuan Huang; Hanqun Liu; Yuwan Lin et al.

    Frontiers in Pharmacology, Vol. 11 · 2021 · English · DOAJ Scopus

    The NLR family pyrin domain containing 3 (NLRP3) inflammasome was reported to be regulated by autophagy and activated during inflammatory procession of Parkinson’s disease (PD). Berberine (BBR) is well-studied to play an important role in promoting anti-inflammatory response to mediate the…

  11. Journal Article

    A Novel Hydrogen Sulfide Donor Reduces Pilocarpine-Induced Status Epilepticus and Regulates Microglial Inflammatory Profile

    Zhongrui Liu; Ziting Zhu; Yan He et al.

    Frontiers in Cellular Neuroscience, Vol. 15 · 2021 · English · DOAJ Scopus

    Although epilepsy is one of the most common neurologic disorders, there is still a lack of effective therapeutic drugs for it. Recently, we synthesized a novel hydrogen sulfide (H2S) donor, which is found to reduce seizures in animal models effectively. But it remains to be determined for its…

  12. Journal Article

    Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease

    Jiewen Qiu; Guoyou Peng; Yuting Tang et al.

    Frontiers in Aging Neuroscience, Vol. 14 · 2023 · English · DOAJ Scopus

    BackgroundParkinson’s disease (PD) is a progressive neurodegenerative disease with characteristic pathological abnormalities, including the loss of dopaminergic (DA) neurons, a dopamine-depleted striatum, and microglial activation. Lipid accumulation exhibits a close relationship with these…

  13. Journal Article

    ATP6V0A1 protects dopaminergic neurons via the autophagy–lysosomal pathway in Parkinson’s disease

    Yuwan Lin; Zixin Tan; Wenfeng Ye et al.

    Neural Regeneration Research, Vol. 21 No. 8 · 2026 · English · DOAJ Scopus

    Parkinson’s disease is the second most common neurodegenerative disorder. ATPase H+ transporting V0 subunit A1 (ATP6V0A1) is a component of vacuolar H+-ATPase (V-ATPase), an ATP-dependent proton pump. Our previous research identified an association between the ATP6V0A1 rs601999 variant and…

  14. Journal Article

    MT1-MMP inhibition rejuvenates ageing brain and rescues cognitive deficits in obesity

    Pallavi Asthana; Liguo Li; Lin Lu et al.

    Cell Discovery, Vol. 11 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Obesity has been linked to an increased risk of cognitive impairment and dementia in later life. Although aging and obesity are both associated with cognitive decline, it remains unclear how they interact to affect cognitive function across the lifespan and how brain function might mediate…